Global Immuno-Oncology Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Immuno-Oncology market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Immuno-Oncology market are covered in Chapter 9:
Eli Lilly and Company
Novartis International AG
Prometheus Therapeutics & Diagnostics
Bristol-Myers Squibb
ImmunoCellular Therapeutics
Hoffmann-La Roche AG
Johnson & Johnson
Celgene Corporation
Galena Biopharma
Aduro BioTech
AstraZeneca, Plc
AbbVie
EMD Serono
Pfizer Inc.
Incyte
Merck & Co.
Celldex Therapeutics
Amgen, Inc
Gilead Sciences Inc.
Bavarian Nordic
Sanofi S.A.
In Chapter 5 and Chapter 7.3, based on types, the Immuno-Oncology market from 2017 to 2027 is primarily split into:
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Oncolytic Virus
In Chapter 6 and Chapter 7.4, based on applications, the Immuno-Oncology market from 2017 to 2027 covers:
Hospitals
Clinics
Ambulatory Surgical Centers
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Immuno-Oncology market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Immuno-Oncology Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Immuno-Oncology market are covered in Chapter 9:
Eli Lilly and Company
Novartis International AG
Prometheus Therapeutics & Diagnostics
Bristol-Myers Squibb
ImmunoCellular Therapeutics
Hoffmann-La Roche AG
Johnson & Johnson
Celgene Corporation
Galena Biopharma
Aduro BioTech
AstraZeneca, Plc
AbbVie
EMD Serono
Pfizer Inc.
Incyte
Merck & Co.
Celldex Therapeutics
Amgen, Inc
Gilead Sciences Inc.
Bavarian Nordic
Sanofi S.A.
In Chapter 5 and Chapter 7.3, based on types, the Immuno-Oncology market from 2017 to 2027 is primarily split into:
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Oncolytic Virus
In Chapter 6 and Chapter 7.4, based on applications, the Immuno-Oncology market from 2017 to 2027 covers:
Hospitals
Clinics
Ambulatory Surgical Centers
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Immuno-Oncology market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Immuno-Oncology Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 IMMUNO-ONCOLOGY MARKET OVERVIEW
1.1 Product Overview and Scope of Immuno-Oncology Market
1.2 Immuno-Oncology Market Segment by Type
1.2.1 Global Immuno-Oncology Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Immuno-Oncology Market Segment by Application
1.3.1 Immuno-Oncology Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Immuno-Oncology Market, Region Wise (2017-2027)
1.4.1 Global Immuno-Oncology Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Immuno-Oncology Market Status and Prospect (2017-2027)
1.4.3 Europe Immuno-Oncology Market Status and Prospect (2017-2027)
1.4.4 China Immuno-Oncology Market Status and Prospect (2017-2027)
1.4.5 Japan Immuno-Oncology Market Status and Prospect (2017-2027)
1.4.6 India Immuno-Oncology Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Immuno-Oncology Market Status and Prospect (2017-2027)
1.4.8 Latin America Immuno-Oncology Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Immuno-Oncology Market Status and Prospect (2017-2027)
1.5 Global Market Size of Immuno-Oncology (2017-2027)
1.5.1 Global Immuno-Oncology Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Immuno-Oncology Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Immuno-Oncology Market
2 INDUSTRY OUTLOOK
2.1 Immuno-Oncology Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Immuno-Oncology Market Drivers Analysis
2.4 Immuno-Oncology Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Immuno-Oncology Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Immuno-Oncology Industry Development
3 GLOBAL IMMUNO-ONCOLOGY MARKET LANDSCAPE BY PLAYER
3.1 Global Immuno-Oncology Sales Volume and Share by Player (2017-2022)
3.2 Global Immuno-Oncology Revenue and Market Share by Player (2017-2022)
3.3 Global Immuno-Oncology Average Price by Player (2017-2022)
3.4 Global Immuno-Oncology Gross Margin by Player (2017-2022)
3.5 Immuno-Oncology Market Competitive Situation and Trends
3.5.1 Immuno-Oncology Market Concentration Rate
3.5.2 Immuno-Oncology Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL IMMUNO-ONCOLOGY SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Immuno-Oncology Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Immuno-Oncology Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Immuno-Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Immuno-Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Immuno-Oncology Market Under COVID-19
4.5 Europe Immuno-Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Immuno-Oncology Market Under COVID-19
4.6 China Immuno-Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Immuno-Oncology Market Under COVID-19
4.7 Japan Immuno-Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Immuno-Oncology Market Under COVID-19
4.8 India Immuno-Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Immuno-Oncology Market Under COVID-19
4.9 Southeast Asia Immuno-Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Immuno-Oncology Market Under COVID-19
4.10 Latin America Immuno-Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Immuno-Oncology Market Under COVID-19
4.11 Middle East and Africa Immuno-Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Immuno-Oncology Market Under COVID-19
5 GLOBAL IMMUNO-ONCOLOGY SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Immuno-Oncology Sales Volume and Market Share by Type (2017-2022)
5.2 Global Immuno-Oncology Revenue and Market Share by Type (2017-2022)
5.3 Global Immuno-Oncology Price by Type (2017-2022)
5.4 Global Immuno-Oncology Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Immuno-Oncology Sales Volume, Revenue and Growth Rate of Immune Checkpoint Inhibitors (2017-2022)
5.4.2 Global Immuno-Oncology Sales Volume, Revenue and Growth Rate of Immune System Modulators (2017-2022)
5.4.3 Global Immuno-Oncology Sales Volume, Revenue and Growth Rate of Cancer Vaccines (2017-2022)
5.4.4 Global Immuno-Oncology Sales Volume, Revenue and Growth Rate of Oncolytic Virus (2017-2022)
6 GLOBAL IMMUNO-ONCOLOGY MARKET ANALYSIS BY APPLICATION
6.1 Global Immuno-Oncology Consumption and Market Share by Application (2017-2022)
6.2 Global Immuno-Oncology Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Immuno-Oncology Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Immuno-Oncology Consumption and Growth Rate of Hospitals (2017-2022)
6.3.2 Global Immuno-Oncology Consumption and Growth Rate of Clinics (2017-2022)
6.3.3 Global Immuno-Oncology Consumption and Growth Rate of Ambulatory Surgical Centers (2017-2022)
7 GLOBAL IMMUNO-ONCOLOGY MARKET FORECAST (2022-2027)
7.1 Global Immuno-Oncology Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Immuno-Oncology Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Immuno-Oncology Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Immuno-Oncology Price and Trend Forecast (2022-2027)
7.2 Global Immuno-Oncology Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Immuno-Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Immuno-Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Immuno-Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Immuno-Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Immuno-Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Immuno-Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Immuno-Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Immuno-Oncology Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Immuno-Oncology Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Immuno-Oncology Revenue and Growth Rate of Immune Checkpoint Inhibitors (2022-2027)
7.3.2 Global Immuno-Oncology Revenue and Growth Rate of Immune System Modulators (2022-2027)
7.3.3 Global Immuno-Oncology Revenue and Growth Rate of Cancer Vaccines (2022-2027)
7.3.4 Global Immuno-Oncology Revenue and Growth Rate of Oncolytic Virus (2022-2027)
7.4 Global Immuno-Oncology Consumption Forecast by Application (2022-2027)
7.4.1 Global Immuno-Oncology Consumption Value and Growth Rate of Hospitals(2022-2027)
7.4.2 Global Immuno-Oncology Consumption Value and Growth Rate of Clinics(2022-2027)
7.4.3 Global Immuno-Oncology Consumption Value and Growth Rate of Ambulatory Surgical Centers(2022-2027)
7.5 Immuno-Oncology Market Forecast Under COVID-19
8 IMMUNO-ONCOLOGY MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Immuno-Oncology Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Immuno-Oncology Analysis
8.6 Major Downstream Buyers of Immuno-Oncology Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Immuno-Oncology Industry
9 PLAYERS PROFILES
9.1 Eli Lilly and Company
9.1.1 Eli Lilly and Company Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Immuno-Oncology Product Profiles, Application and Specification
9.1.3 Eli Lilly and Company Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Novartis International AG
9.2.1 Novartis International AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Immuno-Oncology Product Profiles, Application and Specification
9.2.3 Novartis International AG Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Prometheus Therapeutics & Diagnostics
9.3.1 Prometheus Therapeutics & Diagnostics Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Immuno-Oncology Product Profiles, Application and Specification
9.3.3 Prometheus Therapeutics & Diagnostics Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Bristol-Myers Squibb
9.4.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Immuno-Oncology Product Profiles, Application and Specification
9.4.3 Bristol-Myers Squibb Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 ImmunoCellular Therapeutics
9.5.1 ImmunoCellular Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Immuno-Oncology Product Profiles, Application and Specification
9.5.3 ImmunoCellular Therapeutics Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Hoffmann-La Roche AG
9.6.1 Hoffmann-La Roche AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Immuno-Oncology Product Profiles, Application and Specification
9.6.3 Hoffmann-La Roche AG Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Johnson & Johnson
9.7.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Immuno-Oncology Product Profiles, Application and Specification
9.7.3 Johnson & Johnson Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Celgene Corporation
9.8.1 Celgene Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Immuno-Oncology Product Profiles, Application and Specification
9.8.3 Celgene Corporation Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Galena Biopharma
9.9.1 Galena Biopharma Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Immuno-Oncology Product Profiles, Application and Specification
9.9.3 Galena Biopharma Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Aduro BioTech
9.10.1 Aduro BioTech Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Immuno-Oncology Product Profiles, Application and Specification
9.10.3 Aduro BioTech Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 AstraZeneca, Plc
9.11.1 AstraZeneca, Plc Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Immuno-Oncology Product Profiles, Application and Specification
9.11.3 AstraZeneca, Plc Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 AbbVie
9.12.1 AbbVie Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Immuno-Oncology Product Profiles, Application and Specification
9.12.3 AbbVie Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 EMD Serono
9.13.1 EMD Serono Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Immuno-Oncology Product Profiles, Application and Specification
9.13.3 EMD Serono Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Pfizer Inc.
9.14.1 Pfizer Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Immuno-Oncology Product Profiles, Application and Specification
9.14.3 Pfizer Inc. Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 Incyte
9.15.1 Incyte Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Immuno-Oncology Product Profiles, Application and Specification
9.15.3 Incyte Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 Merck & Co.
9.16.1 Merck & Co. Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Immuno-Oncology Product Profiles, Application and Specification
9.16.3 Merck & Co. Market Performance (2017-2022)
9.16.4 Recent Development
9.16.5 SWOT Analysis
9.17 Celldex Therapeutics
9.17.1 Celldex Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.17.2 Immuno-Oncology Product Profiles, Application and Specification
9.17.3 Celldex Therapeutics Market Performance (2017-2022)
9.17.4 Recent Development
9.17.5 SWOT Analysis
9.18 Amgen, Inc
9.18.1 Amgen, Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.18.2 Immuno-Oncology Product Profiles, Application and Specification
9.18.3 Amgen, Inc Market Performance (2017-2022)
9.18.4 Recent Development
9.18.5 SWOT Analysis
9.19 Gilead Sciences Inc.
9.19.1 Gilead Sciences Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.19.2 Immuno-Oncology Product Profiles, Application and Specification
9.19.3 Gilead Sciences Inc. Market Performance (2017-2022)
9.19.4 Recent Development
9.19.5 SWOT Analysis
9.20 Bavarian Nordic
9.20.1 Bavarian Nordic Basic Information, Manufacturing Base, Sales Region and Competitors
9.20.2 Immuno-Oncology Product Profiles, Application and Specification
9.20.3 Bavarian Nordic Market Performance (2017-2022)
9.20.4 Recent Development
9.20.5 SWOT Analysis
9.21 Sanofi S.A.
9.21.1 Sanofi S.A. Basic Information, Manufacturing Base, Sales Region and Competitors
9.21.2 Immuno-Oncology Product Profiles, Application and Specification
9.21.3 Sanofi S.A. Market Performance (2017-2022)
9.21.4 Recent Development
9.21.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Immuno-Oncology Market
1.2 Immuno-Oncology Market Segment by Type
1.2.1 Global Immuno-Oncology Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Immuno-Oncology Market Segment by Application
1.3.1 Immuno-Oncology Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Immuno-Oncology Market, Region Wise (2017-2027)
1.4.1 Global Immuno-Oncology Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Immuno-Oncology Market Status and Prospect (2017-2027)
1.4.3 Europe Immuno-Oncology Market Status and Prospect (2017-2027)
1.4.4 China Immuno-Oncology Market Status and Prospect (2017-2027)
1.4.5 Japan Immuno-Oncology Market Status and Prospect (2017-2027)
1.4.6 India Immuno-Oncology Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Immuno-Oncology Market Status and Prospect (2017-2027)
1.4.8 Latin America Immuno-Oncology Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Immuno-Oncology Market Status and Prospect (2017-2027)
1.5 Global Market Size of Immuno-Oncology (2017-2027)
1.5.1 Global Immuno-Oncology Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Immuno-Oncology Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Immuno-Oncology Market
2 INDUSTRY OUTLOOK
2.1 Immuno-Oncology Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Immuno-Oncology Market Drivers Analysis
2.4 Immuno-Oncology Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Immuno-Oncology Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Immuno-Oncology Industry Development
3 GLOBAL IMMUNO-ONCOLOGY MARKET LANDSCAPE BY PLAYER
3.1 Global Immuno-Oncology Sales Volume and Share by Player (2017-2022)
3.2 Global Immuno-Oncology Revenue and Market Share by Player (2017-2022)
3.3 Global Immuno-Oncology Average Price by Player (2017-2022)
3.4 Global Immuno-Oncology Gross Margin by Player (2017-2022)
3.5 Immuno-Oncology Market Competitive Situation and Trends
3.5.1 Immuno-Oncology Market Concentration Rate
3.5.2 Immuno-Oncology Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL IMMUNO-ONCOLOGY SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Immuno-Oncology Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Immuno-Oncology Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Immuno-Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Immuno-Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Immuno-Oncology Market Under COVID-19
4.5 Europe Immuno-Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Immuno-Oncology Market Under COVID-19
4.6 China Immuno-Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Immuno-Oncology Market Under COVID-19
4.7 Japan Immuno-Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Immuno-Oncology Market Under COVID-19
4.8 India Immuno-Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Immuno-Oncology Market Under COVID-19
4.9 Southeast Asia Immuno-Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Immuno-Oncology Market Under COVID-19
4.10 Latin America Immuno-Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Immuno-Oncology Market Under COVID-19
4.11 Middle East and Africa Immuno-Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Immuno-Oncology Market Under COVID-19
5 GLOBAL IMMUNO-ONCOLOGY SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Immuno-Oncology Sales Volume and Market Share by Type (2017-2022)
5.2 Global Immuno-Oncology Revenue and Market Share by Type (2017-2022)
5.3 Global Immuno-Oncology Price by Type (2017-2022)
5.4 Global Immuno-Oncology Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Immuno-Oncology Sales Volume, Revenue and Growth Rate of Immune Checkpoint Inhibitors (2017-2022)
5.4.2 Global Immuno-Oncology Sales Volume, Revenue and Growth Rate of Immune System Modulators (2017-2022)
5.4.3 Global Immuno-Oncology Sales Volume, Revenue and Growth Rate of Cancer Vaccines (2017-2022)
5.4.4 Global Immuno-Oncology Sales Volume, Revenue and Growth Rate of Oncolytic Virus (2017-2022)
6 GLOBAL IMMUNO-ONCOLOGY MARKET ANALYSIS BY APPLICATION
6.1 Global Immuno-Oncology Consumption and Market Share by Application (2017-2022)
6.2 Global Immuno-Oncology Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Immuno-Oncology Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Immuno-Oncology Consumption and Growth Rate of Hospitals (2017-2022)
6.3.2 Global Immuno-Oncology Consumption and Growth Rate of Clinics (2017-2022)
6.3.3 Global Immuno-Oncology Consumption and Growth Rate of Ambulatory Surgical Centers (2017-2022)
7 GLOBAL IMMUNO-ONCOLOGY MARKET FORECAST (2022-2027)
7.1 Global Immuno-Oncology Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Immuno-Oncology Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Immuno-Oncology Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Immuno-Oncology Price and Trend Forecast (2022-2027)
7.2 Global Immuno-Oncology Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Immuno-Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Immuno-Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Immuno-Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Immuno-Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Immuno-Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Immuno-Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Immuno-Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Immuno-Oncology Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Immuno-Oncology Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Immuno-Oncology Revenue and Growth Rate of Immune Checkpoint Inhibitors (2022-2027)
7.3.2 Global Immuno-Oncology Revenue and Growth Rate of Immune System Modulators (2022-2027)
7.3.3 Global Immuno-Oncology Revenue and Growth Rate of Cancer Vaccines (2022-2027)
7.3.4 Global Immuno-Oncology Revenue and Growth Rate of Oncolytic Virus (2022-2027)
7.4 Global Immuno-Oncology Consumption Forecast by Application (2022-2027)
7.4.1 Global Immuno-Oncology Consumption Value and Growth Rate of Hospitals(2022-2027)
7.4.2 Global Immuno-Oncology Consumption Value and Growth Rate of Clinics(2022-2027)
7.4.3 Global Immuno-Oncology Consumption Value and Growth Rate of Ambulatory Surgical Centers(2022-2027)
7.5 Immuno-Oncology Market Forecast Under COVID-19
8 IMMUNO-ONCOLOGY MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Immuno-Oncology Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Immuno-Oncology Analysis
8.6 Major Downstream Buyers of Immuno-Oncology Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Immuno-Oncology Industry
9 PLAYERS PROFILES
9.1 Eli Lilly and Company
9.1.1 Eli Lilly and Company Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Immuno-Oncology Product Profiles, Application and Specification
9.1.3 Eli Lilly and Company Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Novartis International AG
9.2.1 Novartis International AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Immuno-Oncology Product Profiles, Application and Specification
9.2.3 Novartis International AG Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Prometheus Therapeutics & Diagnostics
9.3.1 Prometheus Therapeutics & Diagnostics Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Immuno-Oncology Product Profiles, Application and Specification
9.3.3 Prometheus Therapeutics & Diagnostics Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Bristol-Myers Squibb
9.4.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Immuno-Oncology Product Profiles, Application and Specification
9.4.3 Bristol-Myers Squibb Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 ImmunoCellular Therapeutics
9.5.1 ImmunoCellular Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Immuno-Oncology Product Profiles, Application and Specification
9.5.3 ImmunoCellular Therapeutics Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Hoffmann-La Roche AG
9.6.1 Hoffmann-La Roche AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Immuno-Oncology Product Profiles, Application and Specification
9.6.3 Hoffmann-La Roche AG Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Johnson & Johnson
9.7.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Immuno-Oncology Product Profiles, Application and Specification
9.7.3 Johnson & Johnson Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Celgene Corporation
9.8.1 Celgene Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Immuno-Oncology Product Profiles, Application and Specification
9.8.3 Celgene Corporation Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Galena Biopharma
9.9.1 Galena Biopharma Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Immuno-Oncology Product Profiles, Application and Specification
9.9.3 Galena Biopharma Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Aduro BioTech
9.10.1 Aduro BioTech Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Immuno-Oncology Product Profiles, Application and Specification
9.10.3 Aduro BioTech Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 AstraZeneca, Plc
9.11.1 AstraZeneca, Plc Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Immuno-Oncology Product Profiles, Application and Specification
9.11.3 AstraZeneca, Plc Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 AbbVie
9.12.1 AbbVie Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Immuno-Oncology Product Profiles, Application and Specification
9.12.3 AbbVie Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 EMD Serono
9.13.1 EMD Serono Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Immuno-Oncology Product Profiles, Application and Specification
9.13.3 EMD Serono Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Pfizer Inc.
9.14.1 Pfizer Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Immuno-Oncology Product Profiles, Application and Specification
9.14.3 Pfizer Inc. Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 Incyte
9.15.1 Incyte Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Immuno-Oncology Product Profiles, Application and Specification
9.15.3 Incyte Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 Merck & Co.
9.16.1 Merck & Co. Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Immuno-Oncology Product Profiles, Application and Specification
9.16.3 Merck & Co. Market Performance (2017-2022)
9.16.4 Recent Development
9.16.5 SWOT Analysis
9.17 Celldex Therapeutics
9.17.1 Celldex Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.17.2 Immuno-Oncology Product Profiles, Application and Specification
9.17.3 Celldex Therapeutics Market Performance (2017-2022)
9.17.4 Recent Development
9.17.5 SWOT Analysis
9.18 Amgen, Inc
9.18.1 Amgen, Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.18.2 Immuno-Oncology Product Profiles, Application and Specification
9.18.3 Amgen, Inc Market Performance (2017-2022)
9.18.4 Recent Development
9.18.5 SWOT Analysis
9.19 Gilead Sciences Inc.
9.19.1 Gilead Sciences Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.19.2 Immuno-Oncology Product Profiles, Application and Specification
9.19.3 Gilead Sciences Inc. Market Performance (2017-2022)
9.19.4 Recent Development
9.19.5 SWOT Analysis
9.20 Bavarian Nordic
9.20.1 Bavarian Nordic Basic Information, Manufacturing Base, Sales Region and Competitors
9.20.2 Immuno-Oncology Product Profiles, Application and Specification
9.20.3 Bavarian Nordic Market Performance (2017-2022)
9.20.4 Recent Development
9.20.5 SWOT Analysis
9.21 Sanofi S.A.
9.21.1 Sanofi S.A. Basic Information, Manufacturing Base, Sales Region and Competitors
9.21.2 Immuno-Oncology Product Profiles, Application and Specification
9.21.3 Sanofi S.A. Market Performance (2017-2022)
9.21.4 Recent Development
9.21.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Immuno-Oncology Product Picture
Table Global Immuno-Oncology Market Sales Volume and CAGR (%) Comparison by Type
Table Immuno-Oncology Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Immuno-Oncology Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Immuno-Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Immuno-Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Immuno-Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Immuno-Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Immuno-Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Immuno-Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Immuno-Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Immuno-Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Immuno-Oncology Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Immuno-Oncology Industry Development
Table Global Immuno-Oncology Sales Volume by Player (2017-2022)
Table Global Immuno-Oncology Sales Volume Share by Player (2017-2022)
Figure Global Immuno-Oncology Sales Volume Share by Player in 2021
Table Immuno-Oncology Revenue (Million USD) by Player (2017-2022)
Table Immuno-Oncology Revenue Market Share by Player (2017-2022)
Table Immuno-Oncology Price by Player (2017-2022)
Table Immuno-Oncology Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Immuno-Oncology Sales Volume, Region Wise (2017-2022)
Table Global Immuno-Oncology Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Immuno-Oncology Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Immuno-Oncology Sales Volume Market Share, Region Wise in 2021
Table Global Immuno-Oncology Revenue (Million USD), Region Wise (2017-2022)
Table Global Immuno-Oncology Revenue Market Share, Region Wise (2017-2022)
Figure Global Immuno-Oncology Revenue Market Share, Region Wise (2017-2022)
Figure Global Immuno-Oncology Revenue Market Share, Region Wise in 2021
Table Global Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Immuno-Oncology Sales Volume by Type (2017-2022)
Table Global Immuno-Oncology Sales Volume Market Share by Type (2017-2022)
Figure Global Immuno-Oncology Sales Volume Market Share by Type in 2021
Table Global Immuno-Oncology Revenue (Million USD) by Type (2017-2022)
Table Global Immuno-Oncology Revenue Market Share by Type (2017-2022)
Figure Global Immuno-Oncology Revenue Market Share by Type in 2021
Table Immuno-Oncology Price by Type (2017-2022)
Figure Global Immuno-Oncology Sales Volume and Growth Rate of Immune Checkpoint Inhibitors (2017-2022)
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate of Immune Checkpoint Inhibitors (2017-2022)
Figure Global Immuno-Oncology Sales Volume and Growth Rate of Immune System Modulators (2017-2022)
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate of Immune System Modulators (2017-2022)
Figure Global Immuno-Oncology Sales Volume and Growth Rate of Cancer Vaccines (2017-2022)
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate of Cancer Vaccines (2017-2022)
Figure Global Immuno-Oncology Sales Volume and Growth Rate of Oncolytic Virus (2017-2022)
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate of Oncolytic Virus (2017-2022)
Table Global Immuno-Oncology Consumption by Application (2017-2022)
Table Global Immuno-Oncology Consumption Market Share by Application (2017-2022)
Table Global Immuno-Oncology Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Immuno-Oncology Consumption Revenue Market Share by Application (2017-2022)
Table Global Immuno-Oncology Consumption and Growth Rate of Hospitals (2017-2022)
Table Global Immuno-Oncology Consumption and Growth Rate of Clinics (2017-2022)
Table Global Immuno-Oncology Consumption and Growth Rate of Ambulatory Surgical Centers (2017-2022)
Figure Global Immuno-Oncology Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Immuno-Oncology Price and Trend Forecast (2022-2027)
Figure USA Immuno-Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Immuno-Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Immuno-Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Immuno-Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Immuno-Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Immuno-Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Immuno-Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Immuno-Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Immuno-Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Immuno-Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Immuno-Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Immuno-Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Immuno-Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Immuno-Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Immuno-Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Immuno-Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Immuno-Oncology Market Sales Volume Forecast, by Type
Table Global Immuno-Oncology Sales Volume Market Share Forecast, by Type
Table Global Immuno-Oncology Market Revenue (Million USD) Forecast, by Type
Table Global Immuno-Oncology Revenue Market Share Forecast, by Type
Table Global Immuno-Oncology Price Forecast, by Type
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate of Immune Checkpoint Inhibitors (2022-2027)
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate of Immune Checkpoint Inhibitors (2022-2027)
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate of Immune System Modulators (2022-2027)
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate of Immune System Modulators (2022-2027)
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate of Cancer Vaccines (2022-2027)
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate of Cancer Vaccines (2022-2027)
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate of Oncolytic Virus (2022-2027)
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate of Oncolytic Virus (2022-2027)
Table Global Immuno-Oncology Market Consumption Forecast, by Application
Table Global Immuno-Oncology Consumption Market Share Forecast, by Application
Table Global Immuno-Oncology Market Revenue (Million USD) Forecast, by Application
Table Global Immuno-Oncology Revenue Market Share Forecast, by Application
Figure Global Immuno-Oncology Consumption Value (Million USD) and Growth Rate of Hospitals (2022-2027)
Figure Global Immuno-Oncology Consumption Value (Million USD) and Growth Rate of Clinics (2022-2027)
Figure Global Immuno-Oncology Consumption Value (Million USD) and Growth Rate of Ambulatory Surgical Centers (2022-2027)
Figure Immuno-Oncology Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Eli Lilly and Company Profile
Table Eli Lilly and Company Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Eli Lilly and Company Immuno-Oncology Sales Volume and Growth Rate
Figure Eli Lilly and Company Revenue (Million USD) Market Share 2017-2022
Table Novartis International AG Profile
Table Novartis International AG Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis International AG Immuno-Oncology Sales Volume and Growth Rate
Figure Novartis International AG Revenue (Million USD) Market Share 2017-2022
Table Prometheus Therapeutics & Diagnostics Profile
Table Prometheus Therapeutics & Diagnostics Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Prometheus Therapeutics & Diagnostics Immuno-Oncology Sales Volume and Growth Rate
Figure Prometheus Therapeutics & Diagnostics Revenue (Million USD) Market Share 2017-2022
Table Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bristol-Myers Squibb Immuno-Oncology Sales Volume and Growth Rate
Figure Bristol-Myers Squibb Revenue (Million USD) Market Share 2017-2022
Table ImmunoCellular Therapeutics Profile
Table ImmunoCellular Therapeutics Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure ImmunoCellular Therapeutics Immuno-Oncology Sales Volume and Growth Rate
Figure ImmunoCellular Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Hoffmann-La Roche AG Profile
Table Hoffmann-La Roche AG Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Hoffmann-La Roche AG Immuno-Oncology Sales Volume and Growth Rate
Figure Hoffmann-La Roche AG Revenue (Million USD) Market Share 2017-2022
Table Johnson & Johnson Profile
Table Johnson & Johnson Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Johnson & Johnson Immuno-Oncology Sales Volume and Growth Rate
Figure Johnson & Johnson Revenue (Million USD) Market Share 2017-2022
Table Celgene Corporation Profile
Table Celgene Corporation Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Celgene Corporation Immuno-Oncology Sales Volume and Growth Rate
Figure Celgene Corporation Revenue (Million USD) Market Share 2017-2022
Table Galena Biopharma Profile
Table Galena Biopharma Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Galena Biopharma Immuno-Oncology Sales Volume and Growth Rate
Figure Galena Biopharma Revenue (Million USD) Market Share 2017-2022
Table Aduro BioTech Profile
Table Aduro BioTech Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Aduro BioTech Immuno-Oncology Sales Volume and Growth Rate
Figure Aduro BioTech Revenue (Million USD) Market Share 2017-2022
Table AstraZeneca, Plc Profile
Table AstraZeneca, Plc Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AstraZeneca, Plc Immuno-Oncology Sales Volume and Growth Rate
Figure AstraZeneca, Plc Revenue (Million USD) Market Share 2017-2022
Table AbbVie Profile
Table AbbVie Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AbbVie Immuno-Oncology Sales Volume and Growth Rate
Figure AbbVie Revenue (Million USD) Market Share 2017-2022
Table EMD Serono Profile
Table EMD Serono Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure EMD Serono Immuno-Oncology Sales Volume and Growth Rate
Figure EMD Serono Revenue (Million USD) Market Share 2017-2022
Table Pfizer Inc. Profile
Table Pfizer Inc. Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Inc. Immuno-Oncology Sales Volume and Growth Rate
Figure Pfizer Inc. Revenue (Million USD) Market Share 2017-2022
Table Incyte Profile
Table Incyte Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Incyte Immuno-Oncology Sales Volume and Growth Rate
Figure Incyte Revenue (Million USD) Market Share 2017-2022
Table Merck & Co. Profile
Table Merck & Co. Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck & Co. Immuno-Oncology Sales Volume and Growth Rate
Figure Merck & Co. Revenue (Million USD) Market Share 2017-2022
Table Celldex Therapeutics Profile
Table Celldex Therapeutics Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Celldex Therapeutics Immuno-Oncology Sales Volume and Growth Rate
Figure Celldex Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Amgen, Inc Profile
Table Amgen, Inc Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amgen, Inc Immuno-Oncology Sales Volume and Growth Rate
Figure Amgen, Inc Revenue (Million USD) Market Share 2017-2022
Table Gilead Sciences Inc. Profile
Table Gilead Sciences Inc. Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Gilead Sciences Inc. Immuno-Oncology Sales Volume and Growth Rate
Figure Gilead Sciences Inc. Revenue (Million USD) Market Share 2017-2022
Table Bavarian Nordic Profile
Table Bavarian Nordic Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bavarian Nordic Immuno-Oncology Sales Volume and Growth Rate
Figure Bavarian Nordic Revenue (Million USD) Market Share 2017-2022
Table Sanofi S.A. Profile
Table Sanofi S.A. Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sanofi S.A. Immuno-Oncology Sales Volume and Growth Rate
Figure Sanofi S.A. Revenue (Million USD) Market Share 2017-2022
Figure Immuno-Oncology Product Picture
Table Global Immuno-Oncology Market Sales Volume and CAGR (%) Comparison by Type
Table Immuno-Oncology Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Immuno-Oncology Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Immuno-Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Immuno-Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Immuno-Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Immuno-Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Immuno-Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Immuno-Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Immuno-Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Immuno-Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Immuno-Oncology Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Immuno-Oncology Industry Development
Table Global Immuno-Oncology Sales Volume by Player (2017-2022)
Table Global Immuno-Oncology Sales Volume Share by Player (2017-2022)
Figure Global Immuno-Oncology Sales Volume Share by Player in 2021
Table Immuno-Oncology Revenue (Million USD) by Player (2017-2022)
Table Immuno-Oncology Revenue Market Share by Player (2017-2022)
Table Immuno-Oncology Price by Player (2017-2022)
Table Immuno-Oncology Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Immuno-Oncology Sales Volume, Region Wise (2017-2022)
Table Global Immuno-Oncology Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Immuno-Oncology Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Immuno-Oncology Sales Volume Market Share, Region Wise in 2021
Table Global Immuno-Oncology Revenue (Million USD), Region Wise (2017-2022)
Table Global Immuno-Oncology Revenue Market Share, Region Wise (2017-2022)
Figure Global Immuno-Oncology Revenue Market Share, Region Wise (2017-2022)
Figure Global Immuno-Oncology Revenue Market Share, Region Wise in 2021
Table Global Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Immuno-Oncology Sales Volume by Type (2017-2022)
Table Global Immuno-Oncology Sales Volume Market Share by Type (2017-2022)
Figure Global Immuno-Oncology Sales Volume Market Share by Type in 2021
Table Global Immuno-Oncology Revenue (Million USD) by Type (2017-2022)
Table Global Immuno-Oncology Revenue Market Share by Type (2017-2022)
Figure Global Immuno-Oncology Revenue Market Share by Type in 2021
Table Immuno-Oncology Price by Type (2017-2022)
Figure Global Immuno-Oncology Sales Volume and Growth Rate of Immune Checkpoint Inhibitors (2017-2022)
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate of Immune Checkpoint Inhibitors (2017-2022)
Figure Global Immuno-Oncology Sales Volume and Growth Rate of Immune System Modulators (2017-2022)
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate of Immune System Modulators (2017-2022)
Figure Global Immuno-Oncology Sales Volume and Growth Rate of Cancer Vaccines (2017-2022)
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate of Cancer Vaccines (2017-2022)
Figure Global Immuno-Oncology Sales Volume and Growth Rate of Oncolytic Virus (2017-2022)
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate of Oncolytic Virus (2017-2022)
Table Global Immuno-Oncology Consumption by Application (2017-2022)
Table Global Immuno-Oncology Consumption Market Share by Application (2017-2022)
Table Global Immuno-Oncology Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Immuno-Oncology Consumption Revenue Market Share by Application (2017-2022)
Table Global Immuno-Oncology Consumption and Growth Rate of Hospitals (2017-2022)
Table Global Immuno-Oncology Consumption and Growth Rate of Clinics (2017-2022)
Table Global Immuno-Oncology Consumption and Growth Rate of Ambulatory Surgical Centers (2017-2022)
Figure Global Immuno-Oncology Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Immuno-Oncology Price and Trend Forecast (2022-2027)
Figure USA Immuno-Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Immuno-Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Immuno-Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Immuno-Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Immuno-Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Immuno-Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Immuno-Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Immuno-Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Immuno-Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Immuno-Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Immuno-Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Immuno-Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Immuno-Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Immuno-Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Immuno-Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Immuno-Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Immuno-Oncology Market Sales Volume Forecast, by Type
Table Global Immuno-Oncology Sales Volume Market Share Forecast, by Type
Table Global Immuno-Oncology Market Revenue (Million USD) Forecast, by Type
Table Global Immuno-Oncology Revenue Market Share Forecast, by Type
Table Global Immuno-Oncology Price Forecast, by Type
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate of Immune Checkpoint Inhibitors (2022-2027)
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate of Immune Checkpoint Inhibitors (2022-2027)
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate of Immune System Modulators (2022-2027)
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate of Immune System Modulators (2022-2027)
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate of Cancer Vaccines (2022-2027)
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate of Cancer Vaccines (2022-2027)
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate of Oncolytic Virus (2022-2027)
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate of Oncolytic Virus (2022-2027)
Table Global Immuno-Oncology Market Consumption Forecast, by Application
Table Global Immuno-Oncology Consumption Market Share Forecast, by Application
Table Global Immuno-Oncology Market Revenue (Million USD) Forecast, by Application
Table Global Immuno-Oncology Revenue Market Share Forecast, by Application
Figure Global Immuno-Oncology Consumption Value (Million USD) and Growth Rate of Hospitals (2022-2027)
Figure Global Immuno-Oncology Consumption Value (Million USD) and Growth Rate of Clinics (2022-2027)
Figure Global Immuno-Oncology Consumption Value (Million USD) and Growth Rate of Ambulatory Surgical Centers (2022-2027)
Figure Immuno-Oncology Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Eli Lilly and Company Profile
Table Eli Lilly and Company Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Eli Lilly and Company Immuno-Oncology Sales Volume and Growth Rate
Figure Eli Lilly and Company Revenue (Million USD) Market Share 2017-2022
Table Novartis International AG Profile
Table Novartis International AG Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis International AG Immuno-Oncology Sales Volume and Growth Rate
Figure Novartis International AG Revenue (Million USD) Market Share 2017-2022
Table Prometheus Therapeutics & Diagnostics Profile
Table Prometheus Therapeutics & Diagnostics Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Prometheus Therapeutics & Diagnostics Immuno-Oncology Sales Volume and Growth Rate
Figure Prometheus Therapeutics & Diagnostics Revenue (Million USD) Market Share 2017-2022
Table Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bristol-Myers Squibb Immuno-Oncology Sales Volume and Growth Rate
Figure Bristol-Myers Squibb Revenue (Million USD) Market Share 2017-2022
Table ImmunoCellular Therapeutics Profile
Table ImmunoCellular Therapeutics Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure ImmunoCellular Therapeutics Immuno-Oncology Sales Volume and Growth Rate
Figure ImmunoCellular Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Hoffmann-La Roche AG Profile
Table Hoffmann-La Roche AG Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Hoffmann-La Roche AG Immuno-Oncology Sales Volume and Growth Rate
Figure Hoffmann-La Roche AG Revenue (Million USD) Market Share 2017-2022
Table Johnson & Johnson Profile
Table Johnson & Johnson Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Johnson & Johnson Immuno-Oncology Sales Volume and Growth Rate
Figure Johnson & Johnson Revenue (Million USD) Market Share 2017-2022
Table Celgene Corporation Profile
Table Celgene Corporation Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Celgene Corporation Immuno-Oncology Sales Volume and Growth Rate
Figure Celgene Corporation Revenue (Million USD) Market Share 2017-2022
Table Galena Biopharma Profile
Table Galena Biopharma Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Galena Biopharma Immuno-Oncology Sales Volume and Growth Rate
Figure Galena Biopharma Revenue (Million USD) Market Share 2017-2022
Table Aduro BioTech Profile
Table Aduro BioTech Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Aduro BioTech Immuno-Oncology Sales Volume and Growth Rate
Figure Aduro BioTech Revenue (Million USD) Market Share 2017-2022
Table AstraZeneca, Plc Profile
Table AstraZeneca, Plc Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AstraZeneca, Plc Immuno-Oncology Sales Volume and Growth Rate
Figure AstraZeneca, Plc Revenue (Million USD) Market Share 2017-2022
Table AbbVie Profile
Table AbbVie Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AbbVie Immuno-Oncology Sales Volume and Growth Rate
Figure AbbVie Revenue (Million USD) Market Share 2017-2022
Table EMD Serono Profile
Table EMD Serono Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure EMD Serono Immuno-Oncology Sales Volume and Growth Rate
Figure EMD Serono Revenue (Million USD) Market Share 2017-2022
Table Pfizer Inc. Profile
Table Pfizer Inc. Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Inc. Immuno-Oncology Sales Volume and Growth Rate
Figure Pfizer Inc. Revenue (Million USD) Market Share 2017-2022
Table Incyte Profile
Table Incyte Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Incyte Immuno-Oncology Sales Volume and Growth Rate
Figure Incyte Revenue (Million USD) Market Share 2017-2022
Table Merck & Co. Profile
Table Merck & Co. Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck & Co. Immuno-Oncology Sales Volume and Growth Rate
Figure Merck & Co. Revenue (Million USD) Market Share 2017-2022
Table Celldex Therapeutics Profile
Table Celldex Therapeutics Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Celldex Therapeutics Immuno-Oncology Sales Volume and Growth Rate
Figure Celldex Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Amgen, Inc Profile
Table Amgen, Inc Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amgen, Inc Immuno-Oncology Sales Volume and Growth Rate
Figure Amgen, Inc Revenue (Million USD) Market Share 2017-2022
Table Gilead Sciences Inc. Profile
Table Gilead Sciences Inc. Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Gilead Sciences Inc. Immuno-Oncology Sales Volume and Growth Rate
Figure Gilead Sciences Inc. Revenue (Million USD) Market Share 2017-2022
Table Bavarian Nordic Profile
Table Bavarian Nordic Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bavarian Nordic Immuno-Oncology Sales Volume and Growth Rate
Figure Bavarian Nordic Revenue (Million USD) Market Share 2017-2022
Table Sanofi S.A. Profile
Table Sanofi S.A. Immuno-Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sanofi S.A. Immuno-Oncology Sales Volume and Growth Rate
Figure Sanofi S.A. Revenue (Million USD) Market Share 2017-2022
